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In Brief
Pluripotent stem cell (PSC)-derived cells remain fetal like, and this has become a major impediment to modeling adult diseases. Cho et al. find that PSC-derived cardiomyocytes mature into adult cardiomyocytes when transplanted into neonatal rat hearts. This method can serve as a tool to understand maturation and pathogenesis in human cardiomyocytes.
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INTRODUCTION
It has been a decade since Yamanaka and colleagues found a way to induce the formation of pluripotent stem cells (iPSCs) from adult cells (Takahashi and Yamanaka, 2006) . Pluripotent stem cells (PSCs) are capable of becoming any cell type in principle, so there is tremendous enthusiasm for their use in disease modeling, drug discovery, and regenerative medicine as well as for understanding human development. Consequently, numerous iPSCs have been generated from patients harboring various mutations or diseases (Fox et al., 2014; Tabar and Studer, 2014) . Although they have the potential to model and treat a broad spectrum of human diseases, PSC-derived cells are morphologically and functionally similar to fetal cells. This has become a major and common impediment to their application in modeling and treating late-onset disorders Svendsen, 2013; Tabar and Studer, 2014) .
The PSC field is intensely focused on heart disease because of its worldwide prevalence and high morbidity and mortality. In particular, with methodological advances in differentiating PSCs into cardiomyocytes (CMs), current cardiac PSC research is centering on modeling cardiomyopathy (Kamdar et al., 2015; Lalit et al., 2014) , a leading cause of heart failure. However, cardiomyopathy occurs predominantly in the adult stages, making it difficult to recapitulate the true disease phenotype and validate the efficacy of drugs discovered using PSC-derived CMs (PSC-CMs). For this reason, extensive tissue engineering efforts are underway, with the goal of mature PSC-CMs in vitro. Studies have demonstrated that electrical and mechanical stimulation promotes the structural and functional maturation of PSC-CMs (Nunes et al., 2013; Ruan et al., 2015) . Substrate properties were also shown to play an important role in their maturation (Feaster et al., 2015; Ribeiro et al., 2015) . For instance, myofibril alignment and contractility were significantly enhanced in PSC-CMs grown in micropatterned polyacrylamide (Ribeiro et al., . These studies evince the critical role of the microenvironment in PSC-CM maturation. Developmentally, the maturation of CMs begins at an early embryonic stage and continues throughout the postnatal stages. PSC-CMs resemble early embryonic CMs in structure, function, and gene expression (Robertson et al., 2013) . Transcriptional analysis revealed that PSC-CMs undergo maturation in culture, but are arrested at late embryonic/neonatal stages (Uosaki et al., 2015) . In the present study, we leveraged the potential of the neonatal heart environment to demonstrate that neonatal hearts are capable of maturing PSC-CMs to adult CMs.
RESULTS
In-Vivo-Matured PSC-CMs Are Morphologically and Structurally Indistinguishable from Adult CMs To examine the morphology of PSC-CMs in long-term culture, we differentiated mouse embryonic stem cells (mESCs) into CMs by sequential differentiation of embryonic stem cells (ESCs) into the mesoderm, cardiac progenitor cells (CPCs), and CMs (Cheng et al., 2013; Uosaki et al., 2012) . The resulting CMs were cultured in conditions shown to enhance CM maturation (Lundy et al., 2013) . The mESC-derived CMs (mESC-CMs) increased in size over time but remained mononucleated and irregular in shape, with cytoskeletal disarray, which is similar to neonatal CMs but distinct from adult CMs, which are cylindrical, with a well-organized cytoskeleton ( Figure 1A ). This is consistent with our previous finding that in-vitro-matured PSC-CMs are arrested at a neonatal stage at the molecular level (Uosaki et al., 2015) .
On the basis of the neonatal arrest, we reasoned that a neonatal environment in situ might possess the capability of maturing engrafted PSC-CMs. Because neonatal hearts contain Isl1 + CPCs, which have been shown to become adult CMs without cell fusion (Laugwitz et al., 2005; Zaruba et al., 2010) , we hypothesized that PSC-derived Isl1 + CPCs (PSC-CPCs) could mature along with their host CPCs/CMs when inserted into neonatal myocardium. To test this, we generated an mESC Isl1-Cre; Rosa-RFP; aMHC-GFP line that expresses red fluorescent protein (RFP) constitutively in Isl1 + CPCs and GFP in CMs, which allows tracing of the mESC-CPCs and monitoring of their differentiation into CMs (Shenje et al., 2014) . We purified RFP + CPCs at day 6 by fluorescence-activated cell sorting (FACS) and monitored their development following their intraventricular delivery (2 3 10 5 cells/injection) at postnatal days (P) 1-3 ( Figure S1 ). To avoid immune rejection, NIH nude rats (Liang et al., 1997) were used. On average, we obtained 2,000 RFP + cells per injection site, which was sufficient for subsequent in vivo and in vitro analyses. The CPCs expressed GFP at 1 week post-injection, suggesting their differentiation into CMs, but they were spherical, with a single nucleus ( Figure S2A ). However, they became similar to adult CMs in morphology after 1 month of incubation ( Figure S2A ). A 3D reconstruction of the heart, generated with a tissue-clearing method (Susaki et al., 2014) , revealed that the incubated cells form adult CM-like patches ( Figure 1B ; Movie S1). Connexin43, a gap junction protein, was expressed in the mESC-CMs, indicating coupling with neighboring CMs ( Figure 1C ). The mESC-CMs were not detected by rat cardiac troponin T (cTnT) antibody, which does not cross-react with mouse CMs ( Figures 1D and S2C ), excluding the possibility of cell fusion. These data suggest that early postnatal hearts are capable of maturing mESC-CMs. However, the capability appears to be lost when mESC-CPCs are transplanted at P14 ( Figure S2B ). This may imply the presence of a window similar to that observed for neonatal heart regeneration following tissue excision (Porrello et al., 2011) .
To analyze the morphology of in-vivo-incubated PSC-CMs in detail, PSC-CMs were isolated via enzymatic digestion and compared with endogenous CMs. The mESC-CMs, identified by GFP expression, had a sarcomere structure that was as well organized as that of control adult CMs ( Figure 1E ). The length and width of 1-month incubated mESC-CMs were similar to those of 1-month-old mouse CMs. 2-month-old mESC-CMs were slightly bigger than 1-month-old mESC-CMs but similar to 2-month-old mouse CMs in size ( Figure 1F ). Similar to adult CMs, the mESC-CMs exhibited a high level of binucleation, an indicator of CM maturation (Figures 1G and S2D) .
Formation of transverse (t)-tubules, invaginations of the plasma membrane essential for excitation-contraction coupling in adult CMs, is considered a structural hallmark of CM maturation (Yang et al., 2014) . In rats, t-tubules appear sparsely around 2 weeks after birth and fully develop by the first month (Ziman et al., 2010) . To determine if the in vivo incubation is accompanied by t-tubule formation, we stained myocardial sections with Alexa-Fluor-568-conjugated wheat germ agglutinin (WGA), which binds to sialic acid and N-acetylglucosaminyl residues on the surface membranes of the myocytes. WGA images were thresholded to create binary images of the t-tubule network after excluding the surface membrane from the analysis, and mESC-CMs, which were identified by the GFP marker, were compared with control rat heart myocytes from the same image field to determine the total cell and t-tubule areas and the fraction of the cell occupied by t-tubules ( Figure 1H ). Contrary to mESC-CMs matured in vitro ( Figure S2E ), in-vivo-matured mESC-CMs displayed a t-tubule density that was not significantly different from that of native control myocytes ( Figure 1H ). The presence of t-tubules was further confirmed by transmission electron micrographs, which revealed additional adult CM ultrastructures, such as well-developed mitochondria and sarcomeres (Figure 1I) . The mature CMs were also generated by transplanting immature mESC-CMs isolated at day 8 of ESC differentiation.
In-Vivo-Matured PSC-CMs Exhibit Calcium Transients and Contractility of Adult CMs
To determine if the morphological maturation of mESC-CMs is accompanied by functional maturation, we measured Ca 2+ transients of mESC-CMs matured in the heart versus in culture using the ratiometric dye Fura-2 AM. The peak Ca 2+ transient amplitude of in-vivo-matured mESC-CMs was similar to that of cultured mESC-CMs. However, the time to peak amplitude and rate of return to baseline was significantly shorter in in-vivo-matured mESC-CMs versus cultured mESC-CMs (Figures 2A and 2B ; Table S1 ). The faster kinetics support greater maturation of the calcium cycling apparatus required for Ca 2+ release and re-sequestration compared to that obtained in mESC-CMs cultured in vitro for 10 or 30 days. We further compared Ca 2+ transients of 1-to 2-month matured mESC-CMs to freshly isolated adult myocytes from similar aged mice. The peak amplitude and kinetics of Ca 2+ rise and decay did not significantly differ between these cells (Figures 2C and 2D; Table S1 ).
Contractile properties of isolated in-vivo-matured mESC-CMs were assessed by video microscopy and compared to those of freshly isolated adult cells. This assay cannot be performed in cultured PSC-CMs because of their disorganized sarcomere structure. By contrast, the mESC-CMs and freshly isolated mouse CMs had similar well-defined sarcomere shortening behavior. The 1-month-old cells of either type showed somewhat faster kinetics in mESC-CMs, but this disappeared by 2 months of maturation ( Figures 2C and 2D ; Table S1 ).
In-Vivo-Matured PSC-CMs Show Similar Gene Expression to Adult CMs
We next sought to characterize the transcriptomes of mESC-CMs matured in vivo and in vitro. To do this, the CMs were isolated from hearts or culture after 1 month of incubation and subjected to single-cell RNA-sequencing analysis ( Figure 3A ). Mouse adult CMs were used as a control group. We identified 312 differentially expressed genes (>2-fold change) based on a p value of less than 0.01. Hierarchical clustering analysis revealed that in-vivo-matured CMs clustered closer to adult CMs than in-vitro-matured CMs ( Figure 3B ). Consistently, adult and in-vivo-matured CMs were grouped closer than to in-vitromatured CMs in principal component analysis ( Figure 3C ). This suggests a similarity in gene expression between adult and invivo-matured CMs. Notably, in-vitro-matured CMs showed a more dispersed pattern ( Figure 3C ). This may be attributed to variability in their differentiation and maturation in vitro. Gene ontology (GO) analysis indicated that groups of the differentially expressed genes were related to mitochondrial function and muscle contraction ( Figure 3D ; Table S2 ). This may reflect the increase in mitochondrial biogenesis and sarcomeric organization during maturation.
Postnatal Extracellular Factors Can Promote PSC-CM Maturation In Vitro
The fact that PSC-CMs do not mature beyond neonatal stages in culture (Uosaki et al., 2015) but can be further matured by incubating within neonatal myocardium implies environmental differences between postnatal and prenatal hearts. To gain insights into the environmental potential of postnatal hearts, we analyzed genes expressed differentially during CM maturation and identified 89 genes using our Affymetrix array datasets (Uosaki et al., 2015) . Of those genes, 25 were highly downregulated and 16 were highly upregulated in the postnatal heart. We focused on genes encoding secreted or membrane-bound proteins and found that six of those
were increased in postnatal hearts, determined by qPCR ( Figure S3A ). We subsequently treated mESC-CMs with activators (P7C3 activator of Nampt and dihydroxyphenylglycine (DHPG)-glutamate receptor agonist) and recombinant proteins (CXCL14, IL-15, CCL16, and ADIPOQ) of those factors for different time intervals and assessed their maturation status (Figure S3C) . To generate a genetic readout for the assessment, we utilized the Ingenuity pathway analysis and identified a group of nuclear receptors (NRs) strongly associated with postnatal heart maturation ( Figure S3B ). Upon activating the factors, the majority of NRs were significantly upregulated after 7 days of culture (Figures S3D and S3E) . More NRs were increased over time and after 14 days of culture ( Figure S3F ). This suggests that the extracellular proteins may be an environmental component of postnatal hearts utilized for PSC-CM maturation.
Human PSC-CMs Are Matured to Adult CMs in Rodent Neonatal Hearts Human CMs are analogous to rodent CMs in size and structure, but their maturation transpires over a decade. Because CM development is a conserved process in mammals, we hypothesized that human iPSC-CMs (hiPSC-CMs) can be matured in rat postnatal hearts. To test this, hiPSCs (Takahashi et al., 2007) were labeled with GFP, differentiated into CMs, and incubated in neonatal rat hearts, as described earlier ( Figure 4A ). Similar to mESC-CMs, hiPSC-CMs exhibited adult CM-like features after 1 month of incubation. They were rod shaped, with highly organized sarcomeres ( Figure 4B ), and functionally similar to human adult CMs, with the exception of a faster time to 50% cell relengthening in hiPSC-CMs ( Figures 4C and 4D ; Table S3 ). These data demonstrate that rodent neonates are capable of generating adult CMs from human PSCs. The hiPSC-CMs (B) Representative trace and quantification of Ca 2+ transients, time to peak, and baseline 50% and 90% for in-vitro-matured mESC-CMs at day 10 (n = 13) and 1 month (n = 10) and in-vivo-matured mESC-CMs at 1 month (n = 14). (C) Representative Ca 2+ transients and sarcomere shortening of endogenous mouse CMs and in-vivo-matured mESC-CMs at indicated stages, stimulated at 0.5 Hz with pulse. (D) Quantifications of peak amplitude of Ca 2+ transients and sarcomere shortening, time to peak, and time to baseline 50% and 90%, measured with endogenous mouse CMs at 1 month (n = 10) or adult stage (n = 7) and with in-vivo-matured mESC-CMs at 1 month (n = 8-14) or 2 months (n = 13). Data are mean ± SEM; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; ns, not significant (p > 0.05). p values were determined using the one-way ANOVA (B) or two-way ANOVA (D) with non-parametric multiple comparison. showed 80% binucleation ( Figure 4E) , which is higher than that reported for human CMs (25%-57%) (Olivetti et al., 1996; Schmid and Pfitzer, 1985) .
In-Vivo-Maturation System Allows Modeling Human Arrhythmogenic Right Ventricular Cardiomyopathy
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited form of cardiomyopathy that manifests in adolescence/adulthood in humans and is characterized by fibro-fatty replacement, apoptosis, and intercalated disc abnormalities (Basso et al., 2006; Calkins and Marcus, 2008) . This adult phenotype is recapitulated in our mouse ARVC model (Chelko et al., 2016) ( Figures 5A and 5B ). We next examined ARVC hiPSCs generated from patients with the syndrome (Kim et al., 2013a) .
The resulting ARVC hiPSC-CMs remained fetal-like in both morphology and function and required a lipogenic medium to partially mimic ARVC properties in vitro (Kim et al., 2013a) . Consistently, we found that ARVC hiPSC-CMs matured in vitro did not replicate the adult disease phenotype (Figure 5C ). To test if the neonatal maturation system can be used to model human ARVC, we transplanted GFP-labeled ARVC hiPSC-CMs into neonatal rat hearts and analyzed them after 1 month of incubation. The incubation resulted in the accumulation of lipids/ adipocytes, accompanied by markedly increased apoptosis ( Figures 5D-5F ), recapitulating the disease phenotype. Moreover, electron microscopy showed abnormal intercalated discs (intercellular gap widening) observed in ARVC human patients ( Figure 5G) . 
DISCUSSION
Generation of mature adult CMs from hPSCs has remained intractable. This suggests a substantial complexity to the signaling and stimuli needed for CM maturation that normally takes place over a decade in humans. The current study demonstrates that hPSC-CMs can mature to adult CMs in a month when incubated in rat neonatal myocardium, in which the latter provides a bio-incubator for CM maturation. The resulting CMs can be studied at the single-cell level both in vivo and in vitro, allowing the study of mature human CMs to address the pathogenesis of adult-onset CM diseases. This system may also be used for in vivo drug testing.
A number of studies have demonstrated that PSC-CMs develop a more adult-like phenotype over time in vitro (Robertson et al., 2013; Yang et al., 2014) . Although the precise status of their maturation remains to be determined, a multi-stage, genome-wide analysis indicated that early or late PSC-CMs in culture resemble early embryonic or late embryonic/neonatal CMs, respectively (Uosaki et al., 2015) . The absence of the extensive t-tubule network also supports their immaturity (Kane et al., 2015; Knollmann, 2013) . The in-vivo-incubated PSC-CMs, however, displayed features very similar to those of adult CMs in morphology, function, and gene expression. For example, T-tubules were formed with a regular pattern and invagination as adult CMs, and this is consistent with their adult calcium transients and sarcomere shortening. Moreover, invivo-incubated ARVC hiPSC-CMs showed disease phenotypes that appear in adults. This suggests that the in-vivo-matured PSCs are highly analogous to adult CMs and that this system can be used to study and model human CM development and late-onset CM-autonomous diseases.
Early postnatal hearts contain endogenous CPCs and immature CMs, and we found that exogenously introduced PSC-CPCs/CMs can give rise to mature CMs in the hearts. This finding suggests that young hearts provide the environmental cues necessary to guide PSC-CPCs/CMs to become adult CMs. The cues might come from extracellular factors enriched in postnatal hearts because they were able to promote the molecular maturation of PSC-CMs in vitro. Further analysis will be needed to identify the source of the factors and determine their effects on morphological and functional maturation. Curiously, PSC-CMs remain immature when transplanted into adult hearts (Shiba et al., 2012) , suggesting the presence of a critical time window required for PSC-CM maturation. It will be of great importance to investigate temporal factors present in early postnatal hearts that mediate the process.
It is worth noting that hPSC-CMs mature into adult-like CMs after a month of incubation in rodent hearts. This suggests that the machinery needed for CM maturation might be conserved in rodents and humans. In fact, although rodents have a shorter lifespan, comparative transcriptional analyses revealed that genes involved in mouse CM maturation are similarly regulated during human heart maturation (Uosaki and Taguchi, 2016) . It will be interesting to test if hPSC-CMs can also be matured in larger animal models. This approach may be extended for generating other types of adult cells prone to disease, such as skeletal muscle cells, pancreatic cells, and renal cells, from hiPSCs, which would allow us to study and model adult-onset human diseases.
EXPERIMENTAL PROCEDURES
Animals
All animals were housed at the Johns Hopkins Medical Institutions. All protocols involving animals followed U.S. NIH guidelines and were approved by the animal and care use committee of the Johns Hopkins Medical Institutions. The animals were randomly allocated to experimental groups, and both male and female pups were used for cell delivery. No inclusion or exclusion parameters were used for animal experiments. We were not blinded to the group allocation during the experiment.
Cell Culture, Differentiation, and Delivery mESCs and hESC/iPSCs (Table S4) were obtained, maintained, and differentiated as described (Cheng et al., 2013; Kim et al., 2013a; Uosaki et al., 2011 Uosaki et al., , 2012 . For CPC purification, cells were dissociated at day 7 and resuspended in PBS containing 0.1% fetal bovine serum (FBS), 20 mM HEPES, and 1 mM EDTA. RFP + CPCs were isolated with an SH800 sorter (Sony Biotechnology). For cell delivery, RNU rats (Charles River Laboratories) were used as host animals. Postnatal rats were anesthetized by cooling on an ice bed for 5 min, and a hole was made between the fourth and fifth rib. Before injection, cells were mixed with Iscove's Modified Dulbecco's Medium (IMDM) and matrigel at a 60:1 ratio (Laflamme et al., 2007) and injected into the ventricle wall with the Eppendorf FemtoJet Microinjector (10 mL/injection). To close the hole, we used tissue glue (3M Vetbond tissue adhesive). After injection, pups were recovered on a heating pad for 10 min and returned to the mother. To test mycoplasma contamination, we used the MycoProbe Mycoplasma Detection Kit (R&D Systems, Catalog# CULoo1B). To assess the effect of secreted/ membrane-bound factors, mESC-CMs were either incubated with six factors, CXCL14 (50 ng/mL, Abcam), IL-15 (10 ng/mL, Novus), CCL6 (100 ng/mL, Novus,), and Adipoq (250 ng/mL, Sigma), DHPG (50 nM, Abcam), P7C3 (10 nM, Abcam), or DMSO (control), for 4, 7, and 14 days. The medium was changed every 2 to 3 days. Four independent experiments were performed.
Immunohistochemistry and t-Tubule Analysis
For immunohistochemistry, cultured cells and dissected hearts were fixed in 4% paraformaldehyde, blocked for 1 hr with 1% BSA, and incubated overnight with the following primary antibodies: a-actinin (Sigma A7732), RFP (Clontech Laboratories 5f8), GFP (Life Technologies A11122, A10262), perilipin (Cell Signaling 9349), cTnT (Thermo Scientific MS 295-P1), rat-and human-specific cTnT (Abcam ab45932), connexin 43 (Sigma, C6219), and human mitochondria (Abcam ab92824). Alexa Fluor secondary antibodies (488, 564, and 648, Life Technologies) were used for secondary detection. For fluorescent t-tubule staining, nuclei (DAPI), GFP, and t-tubules (Alexa Fluor 568-conjugated WGA) were imaged using a confocal microscope (Leica DM2500) with a 403 (1.15 NA) oil-immersion lens. WGA images were analyzed using ImageJ (Version 1.50e; Rasband, W.S., ImageJ, U.S. NIH, http://imagej.nih.gov/ij, 1997-2016). A median filter (pixel radius of 1) was applied, the plugin Auto_Local_ Threshold (Niblack method) was used to create a binary mask of the WGA signal, and the mask eroded one time. A region of interest was created for each cell, which excluded the boundary membrane to isolate the t-tubule network for segmentation analysis. The Analyze_Particles plugin was then used to measure the t-tubule area (mm 2 ), which was normalized to the total cell area to calculate the fractional area (expressed as % total). A two-tailed t test was then performed to compare the two groups. Control and mESCderived myocytes from the same optical field were used for statistical comparisons to eliminate errors that could arise because of variable staining efficiency or imaging conditions.
Whole-Organ Optical Clearing and Imaging
To visualize the extent of CM differentiation and incorporation, the heart of CPC-injected mice was perfused with ice-cold saline, followed by 4% paraformaldehyde (PFA) in PBS, and post-fixed overnight. The heart was subsequently subjected to Scale CUBIC-1 tissue clearing solution (Susaki et al., 2014) at 37 C for 7 days with mild shaking. The solution was exchanged with fresh reagents twice. The optically transparent heart was then mounted in the same solution and imaged using a Zeiss LSM 510 or 710 laser scanning confocal microscope with a 103 0.3 NA or 203 0.5 NA objective. 3D renderings of the Z-stack images were made using Imaris (Bitplane).
Measurement of Calcium Transients and Sarcomere Shortening
CMs were freshly isolated from mouse or rat hearts. Hearts were quickly excised under anesthesia, and the aorta was retroperfused with an enzymatic perfusion solution containing collagenase, as described by Bassani and Bers (1994) and Lee et al. (2010) . The isolated CMs were incubated in 1 mM of the ratiometric Ca 2+ indicator dye Fura-2AM (Invitrogen, Molecular Probes) containing 1 mM Ca 2+ 1x Tyrode solution, and then the cells were placed in a perfusion chamber and stimulated at 0.5 Hz with pulses. Sarcomere length and whole-cell Ca 2+ transients were recorded using an inverted fluorescence microscope (Nikon, TE2000) with IonOptix (Myocam) software. To measure Ca 2+ transients with embryonic and postnatal CMs, hearts were minced and enzymatically dissociated with collagenase and trypsin. Cells were then seeded on gelatin-or laminin-coated cover glasses in 10% serum-supplemented serum free differentiation (SFD) medium and analyzed the following day. Differentiated PSC-CMs were replated at day 9 for 10-day studies or day 20 for 30-day studies. Whole-cell Ca 2+ transients were measured as described above. Human left ventricular myocytes were isolated from donor hearts that were not suitable for transplantation, as described previously (Chen et al., 2002) , and isolated myocytes were loaded with Fluo-3 AM for measurements. Myocytes were placed in a heated chamber on the stage of an inverted microscope (Nikon Diaphot) and superfused with Tyrode's solution, shortening was detected by video-edge detection, and intracellular Fluo-3 fluorescence was recorded with Clampex (Molecular Devices), as previously described (Piacentino et al., 2003) . Data were analyzed offline with pClampfit.
Transmission Electron Microscopy
Transmission electron microscopy (TEM) was performed with 1-month-old invivo-matured mESC-CMs and ARVC hiPSC-CMs. Sources of human control and ARVC heart sections were described (Basso et al., 2006) . Heart tissue was fixed with freshly made EM grade 1% glutaraldehyde (Pella), 80 mM phosphate buffer (Sorenson's), and 3 mM magnesium chloride, pH 7.2, at 4 C for 1 hr. To ensure complete fixation, tissues were then microwaved in a Pelco 3400 laboratory grade microwave oven. Tissues were placed in 4-mL uncapped glass vials containing 2 mL of fixative. The vials were then placed in a shallow ice bucket, with the top of the fixative level equal to the top ice level. Two 600-mL beakers containing room-temperature D-H2O were positioned on either side of the ice bucket to serve as heat traps. Samples were microwave pulsed for 10 s, paused for 20 s, and then pulsed again for 10 s. Tissues were allowed to sit in fixative for 5 min, then microwaved again in the same manner. Fixative temperatures never exceeded 27 C. Samples were rinsed in buffer containing 3% sucrose (3 3 15 min), then microwaved twice again as before in secondary fixative. This osmication was performed in 1.5% potassium ferrocyanide-reduced 1% osmium tetroxide in 100 mM phosphate buffer containing 3 mM magnesium chloride. All subsequent steps were performed at 4 C. Tissues were then rinsed in 100 mM maleate buffer (3 3 5 min) containing 3% sucrose, and then en-bloc stained with 1% filtered uranyl acetate in the same buffer for 1 hr. Samples were dehydrated at 4 C up to 70% ethanol when they were brought to room temperature and further dehydrated to 100% ethanol. Samples were embedded with Eponate 12 after a brief acetone transition and finally cured in a 60 C oven for 2 days. 80-nm ultra-thin sections were picked up on formvar-coated 200 mesh nickel grids. Sections were floated on all subsequent steps. All solutions were filtered, except for antibodies, which were centrifuged at 13 K for 5 min. Grids were placed on 3% sodium metaperiodate (aqueous [aq]) for 20 min. After a 15-min D-H2O rinse, grids were placed on 50 mM NH4Cl in TBS for 10 min, followed by 20-min triple serum block (3% Normal Goat Serum [NGS], 3% BSA, and 1% fish gelatin) in Tris-buffered saline with Tween 20 (TBST) (blocking solution). GFP-antibody (mouse) incubation was done at 1:200, with no primary antibody as negative control. Incubations were carried out at 4 C overnight. After 1 hr to equilibrate to room temperature, grids were placed on blocking solution for 10 min, followed by a 1-min rinse in TBS. 12-nm GAM (gold conjugated secondary anti-body, Jackson Immunoresearch) was diluted 1:40 in TBS, and grids were incubated for 2 hr at room temperature in a humidity chamber. After a 10-min TBS incubation, followed by a quick D-H2O rinse, grids were hard fixed in 1% glutaraldehyde in 100 mM sodium cacodylate buffer for 5 min. After a brief D-H2O rinse, grids were stained with 2% uranyl acetate (aq) for 20 min, rinsed again with D-H2O, blot dried, and allowed to sit in grid boxes overnight before viewing.
qPCR mESC-CMs were isolated using trypsin and placed in Trizol (Life Technologies). RNA isolation was performed following the manufacturer's instructions, and cDNA was generated using the high-capacity cDNA reverse transcription kit (Applied Biosystems). All qPCR reactions were performed using the Sybr Select qPCR mix (Thermo Fisher) with indicated primers (Table S5 ). Gene expression levels were normalized to GAPDH.
Library Preparation and Sequencing
Single CMs (aMHC-GFP) were either FACS sorted (SH800, Sony Technologies) or manually picked under the microscope into 96 plates containing water (2.4 mL) with RNase-free DNase I (0.2 mL; NEB) and RNase inhibitor (0.25 mL; NEB). DNase I was inactivated by increasing the temperature (72 C for 3 min), and samples were then stored on ice. Custom-designed 2A oligo 1-mL primer (12 mM, Integrated DNA Technologies [Shin et al., 2015] ) was added and annealed to the polyadenylated RNA by undergoing a temperature increase (72 C for 2 min) and being quenched on ice. A mixture of 1 mL of SMARTscribe reverse transcriptase (Clontech Laboratories), 1 mL of customdesigned TS oligo (12 mM, Integrated DNA Technologies [Shin et al., 2015] ), 0.3 mL of MgCl 2 (200 mM, Sigma), 0.5 mL of RNase inhibitor (Neb), 1 mL of dinucleotide triphosphate (dNTP) (10 mM each, Thermo), and 0.25 mL DTT (100 mM, Invitrogen) were incubated at 42 C for 90 min, which was followed by enzyme inactivation at 70 C for 10 min. A mixture of 29 mL of water, 5 mL of Advantage2 taq polymerase buffer, 2 mL of dNTP (10 mM each, Thermo), 2 mL of custom-designed PCR primer (12 mM, Integrated DNA Technologies [Shin et al., 2015] ), and 2 mL of Advantage2 taq polymerase was directly added to the reverse transcription product, and the amplification was performed for 19 cycles. The amplification product was purified using Ampure XP beads (Beckman-Coulter). Libraries and transposome assembly were made using a previously published protocol (Picelli et al., 2014) . Briefly, 100 pg of total cDNA was added to a 2x tagment DNA Buffer (TD) (2x TAPS buffer: 20 mM TAPS-NaOH, 10 mM MgCl2 (pH 8.5) at 25 C, and 16% weight volume (w/v) PEG 8000), and then spiked with 0.5 mL of 1:64 diluted Tn5 (Epicenter) and incubated for 8 min at 55 C. Tn5 was stripped off from the tagmented DNA by adding 0.2% SDS for a final concentration of 0.05%. Libraries were enriched used KAPAHiFi, which included 5X Kappa Fidelity Buffer, 10 mM dNTPs, and HIFI polymerase, and 1 uL of index primers was used directly in the enrichment PCR amplification of libraries for the Illumina sequencers for a 50-mL reaction. The PCR program was as follows: 5 min at 72 C and 1 min at 95 C, and then 16 cycles at 30 s at 95 C, 30 s at 55 C, 30 s at 72 , and 5 min at 72 . Successful libraries were multiplexed and sequenced using NextSeq 500. For analysis, trimmed reads ( Figure 3A) were mapped to the mouse reference genome (GRCm38/mm10) using Tophat (2.1.0) (Kim et al., 2013b) . Cells with >100,000 aligned reads were assembled in python package HTseq (Anders et al., 2015) , and then analyzed for differential expression in the single cell differential expression (SCDE) package (Kharchenko et al., 2014) and DESeq2 package (Love et al., 2014) in R. Gene ontology analysis results were visualized using Revigo (Supek et al., 2011) .
Binucleation Analysis
CMs were isolated from rat hearts using the Langendorff technique. Cardiomyocytes in single-cell dispersion were stained using antibodies against RFP (ChromoTeck), GFP, and cTnT (Thermo Fisher) and DAPI. Cells were analyzed by FACS (SH800, Sony Biotechnologies) and microscopy (EVOSfl, AMG) to determine the nuclear content percentage and nucleation status.
TUNEL Staining
In Situ Cell Death Detection Kit, TMR red (Roche Applied Science, cat# 12156792910), was used for TUNEL staining.
Statistical Analyses
For all analyses, the sample size is described in the figure legends. Most of the in vitro studies were done with two to three sets of independent experiments. Two-group analysis used either Student's t test or the non-parametric Mann-Whitney test. Comparisons of multiple groups were performed using either one-way or two-way ANOVA (if appropriate). If normality or equal variance tests failed, then a Kruskal Wallis test was used. Post hoc multiple comparisons testing used either a Tukey's or Dunn's test. p < 0.05 was considered significant.
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